These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17509958)

  • 21. Effect of bosentan on plasma markers of endothelial cell activity in patients with secondary pulmonary hypertension related to connective tissue diseases.
    Cella G; Vianello F; Cozzi F; Marotta H; Tona F; Saggiorato G; Iqbal O; Fareed J
    J Rheumatol; 2009 Apr; 36(4):760-7. PubMed ID: 19208592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities.
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S; Ciołkiewicz M
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):179-85. PubMed ID: 17557150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus.
    Plazak W; Gryga K; Milewski M; Podolec M; Kostkiewicz M; Podolec P; Musial J
    Lupus; 2011 Aug; 20(9):936-44. PubMed ID: 21636627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease.
    Ferroni P; Basili S; Martini F; Vieri M; Labbadia G; Cordova C; Alessandri C; Gazzaniga PP
    J Investig Med; 2000 Jan; 48(1):21-7. PubMed ID: 10695266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pulmonary hypertension associated with systemic lupus erythematosus].
    Haas C
    Bull Acad Natl Med; 2004; 188(6):985-97; discussion 997. PubMed ID: 15651427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.
    Hasegawa EM; Caleiro MT; Fuller R; Carvalho JF
    Lupus; 2009 Jun; 18(7):618-21. PubMed ID: 19433462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between serum marker variations and pulmonary hypertension secondary to chronic obstructive pulmonary disease].
    Xie X; Wang X; Zhang Y; Han D; Li S; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1458-62. PubMed ID: 24144746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity.
    Pruzanski W; Goulding NJ; Flower RJ; Gladman DD; Urowitz MB; Goodman PJ; Scott KF; Vadas P
    J Rheumatol; 1994 Feb; 21(2):252-7. PubMed ID: 8182633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
    Marie I; Jouen F; Hellot MF; Levesque H
    Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of antiphospholipid antibodies in patients with subacute and chronic cutaneous lupus erythematosus.
    García-Martín P; García-García C; Fraga J; García-Díez A
    Actas Dermosifiliogr; 2013 Apr; 104(3):232-8. PubMed ID: 23332556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S
    Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.
    Douketis JD; Crowther MA; Julian JA; Stewart K; Donovan D; Kaminska EA; Laskin CA; Ginsberg JS
    Thromb Haemost; 1999 Sep; 82(3):1028-32. PubMed ID: 10494759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
    Fojtík Z; Beránek M; Klabusay M; Korístek Z; Buliková A
    Vnitr Lek; 2004 Apr; 50(4):267-73. PubMed ID: 15214295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever.
    Bodur H; Akinci E; Ongürü P; Uyar Y; Baştürk B; Gözel MG; Kayaaslan BU
    Int J Infect Dis; 2010 Aug; 14(8):e704-7. PubMed ID: 20627646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM; Maaty A; Kalil FA
    Arch Pathol Lab Med; 2011 Nov; 135(11):1482-5. PubMed ID: 22032577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Tie2 receptor antagonist angiopoietin-2 in systemic lupus erythematosus: its correlation with various disease activity parameters.
    Salama MK; Taha FM; Safwat M; Darweesh HE; Basel ME
    Immunol Invest; 2012; 41(8):864-75. PubMed ID: 22989097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.